Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Biologics Contract Development and Manufacturing Organization Market

ID: MRFR/HC/38806-HCR
128 Pages
Rahul Gotadki
Last Updated: April 06, 2026

Biologics Contract Development and Manufacturing Organization (CDMO) Market Research Report: Size, Share, Trend Analysis By Service Type (Analytical Development, Quality Control Testing, Clinical Manufacturing, Commercial Manufacturing), By Biologics Type (Monoclonal Antibodies, Recombinant Proteins, Cell and Gene Therapies, Vaccines), By Scale of Operation (Medium Scale, Large Scale), By Production Technology (Mammalian Cell Culture, Microbial Fermentation, Plant-based Expression Systems), By End Users (Biotechnology Companies, Academic Institutions) and By Regional (North America, Europe, South America, Asia-Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Biologics Contract Development and Manufacturing Organization Market Infographic
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Service Type (USD Billion)
      1. 4.1.1 Process Development
      2. 4.1.2 Analytical Development
      3. 4.1.3 Quality Control Testing
      4. 4.1.4 Clinical Manufacturing
      5. 4.1.5 Commercial Manufacturing
    2. 4.2 Healthcare, BY Biologics Type (USD Billion)
      1. 4.2.1 Monoclonal Antibodies
      2. 4.2.2 Recombinant Proteins
      3. 4.2.3 Cell and Gene Therapies
      4. 4.2.4 Vaccines
    3. 4.3 Healthcare, BY Scale of Operation (USD Billion)
      1. 4.3.1 Small Scale
      2. 4.3.2 Medium Scale
      3. 4.3.3 Large Scale
    4. 4.4 Healthcare, BY Production Technology (USD Billion)
      1. 4.4.1 Mammalian Cell Culture
      2. 4.4.2 Microbial Fermentation
      3. 4.4.3 Plant-based Expression Systems
    5. 4.5 Healthcare, BY End User (USD Billion)
      1. 4.5.1 Pharmaceutical Companies
      2. 4.5.2 Biotechnology Companies
      3. 4.5.3 Academic Institutions
    6. 4.6 Healthcare, BY Region (USD Billion)
      1. 4.6.1 North America
        1. 4.6.1.1 US
        2. 4.6.1.2 Canada
      2. 4.6.2 Europe
        1. 4.6.2.1 Germany
        2. 4.6.2.2 UK
        3. 4.6.2.3 France
        4. 4.6.2.4 Russia
        5. 4.6.2.5 Italy
        6. 4.6.2.6 Spain
        7. 4.6.2.7 Rest of Europe
      3. 4.6.3 APAC
        1. 4.6.3.1 China
        2. 4.6.3.2 India
        3. 4.6.3.3 Japan
        4. 4.6.3.4 South Korea
        5. 4.6.3.5 Malaysia
        6. 4.6.3.6 Thailand
        7. 4.6.3.7 Indonesia
        8. 4.6.3.8 Rest of APAC
      4. 4.6.4 South America
        1. 4.6.4.1 Brazil
        2. 4.6.4.2 Mexico
        3. 4.6.4.3 Argentina
        4. 4.6.4.4 Rest of South America
      5. 4.6.5 MEA
        1. 4.6.5.1 GCC Countries
        2. 4.6.5.2 South Africa
        3. 4.6.5.3 Rest of MEA
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Lonza (CH)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Samsung Biologics (KR)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Boehringer Ingelheim (DE)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 WuXi AppTec (CN)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Catalent (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Fujifilm Diosynth Biotechnologies (JP)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Recipharm (SE)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 KBI Biopharma (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Avid Bioservices (US)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 NORTH AMERICA MARKET ANALYSIS
    3. 6.3 US MARKET ANALYSIS BY SERVICE TYPE
    4. 6.4 US MARKET ANALYSIS BY BIOLOGICS TYPE
    5. 6.5 US MARKET ANALYSIS BY SCALE OF OPERATION
    6. 6.6 US MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
    7. 6.7 US MARKET ANALYSIS BY END USER
    8. 6.8 CANADA MARKET ANALYSIS BY SERVICE TYPE
    9. 6.9 CANADA MARKET ANALYSIS BY BIOLOGICS TYPE
    10. 6.10 CANADA MARKET ANALYSIS BY SCALE OF OPERATION
    11. 6.11 CANADA MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
    12. 6.12 CANADA MARKET ANALYSIS BY END USER
    13. 6.13 EUROPE MARKET ANALYSIS
    14. 6.14 GERMANY MARKET ANALYSIS BY SERVICE TYPE
    15. 6.15 GERMANY MARKET ANALYSIS BY BIOLOGICS TYPE
    16. 6.16 GERMANY MARKET ANALYSIS BY SCALE OF OPERATION
    17. 6.17 GERMANY MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
    18. 6.18 GERMANY MARKET ANALYSIS BY END USER
    19. 6.19 UK MARKET ANALYSIS BY SERVICE TYPE
    20. 6.20 UK MARKET ANALYSIS BY BIOLOGICS TYPE
    21. 6.21 UK MARKET ANALYSIS BY SCALE OF OPERATION
    22. 6.22 UK MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
    23. 6.23 UK MARKET ANALYSIS BY END USER
    24. 6.24 FRANCE MARKET ANALYSIS BY SERVICE TYPE
    25. 6.25 FRANCE MARKET ANALYSIS BY BIOLOGICS TYPE
    26. 6.26 FRANCE MARKET ANALYSIS BY SCALE OF OPERATION
    27. 6.27 FRANCE MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
    28. 6.28 FRANCE MARKET ANALYSIS BY END USER
    29. 6.29 RUSSIA MARKET ANALYSIS BY SERVICE TYPE
    30. 6.30 RUSSIA MARKET ANALYSIS BY BIOLOGICS TYPE
    31. 6.31 RUSSIA MARKET ANALYSIS BY SCALE OF OPERATION
    32. 6.32 RUSSIA MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
    33. 6.33 RUSSIA MARKET ANALYSIS BY END USER
    34. 6.34 ITALY MARKET ANALYSIS BY SERVICE TYPE
    35. 6.35 ITALY MARKET ANALYSIS BY BIOLOGICS TYPE
    36. 6.36 ITALY MARKET ANALYSIS BY SCALE OF OPERATION
    37. 6.37 ITALY MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
    38. 6.38 ITALY MARKET ANALYSIS BY END USER
    39. 6.39 SPAIN MARKET ANALYSIS BY SERVICE TYPE
    40. 6.40 SPAIN MARKET ANALYSIS BY BIOLOGICS TYPE
    41. 6.41 SPAIN MARKET ANALYSIS BY SCALE OF OPERATION
    42. 6.42 SPAIN MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
    43. 6.43 SPAIN MARKET ANALYSIS BY END USER
    44. 6.44 REST OF EUROPE MARKET ANALYSIS BY SERVICE TYPE
    45. 6.45 REST OF EUROPE MARKET ANALYSIS BY BIOLOGICS TYPE
    46. 6.46 REST OF EUROPE MARKET ANALYSIS BY SCALE OF OPERATION
    47. 6.47 REST OF EUROPE MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
    48. 6.48 REST OF EUROPE MARKET ANALYSIS BY END USER
    49. 6.49 APAC MARKET ANALYSIS
    50. 6.50 CHINA MARKET ANALYSIS BY SERVICE TYPE
    51. 6.51 CHINA MARKET ANALYSIS BY BIOLOGICS TYPE
    52. 6.52 CHINA MARKET ANALYSIS BY SCALE OF OPERATION
    53. 6.53 CHINA MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
    54. 6.54 CHINA MARKET ANALYSIS BY END USER
    55. 6.55 INDIA MARKET ANALYSIS BY SERVICE TYPE
    56. 6.56 INDIA MARKET ANALYSIS BY BIOLOGICS TYPE
    57. 6.57 INDIA MARKET ANALYSIS BY SCALE OF OPERATION
    58. 6.58 INDIA MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
    59. 6.59 INDIA MARKET ANALYSIS BY END USER
    60. 6.60 JAPAN MARKET ANALYSIS BY SERVICE TYPE
    61. 6.61 JAPAN MARKET ANALYSIS BY BIOLOGICS TYPE
    62. 6.62 JAPAN MARKET ANALYSIS BY SCALE OF OPERATION
    63. 6.63 JAPAN MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
    64. 6.64 JAPAN MARKET ANALYSIS BY END USER
    65. 6.65 SOUTH KOREA MARKET ANALYSIS BY SERVICE TYPE
    66. 6.66 SOUTH KOREA MARKET ANALYSIS BY BIOLOGICS TYPE
    67. 6.67 SOUTH KOREA MARKET ANALYSIS BY SCALE OF OPERATION
    68. 6.68 SOUTH KOREA MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
    69. 6.69 SOUTH KOREA MARKET ANALYSIS BY END USER
    70. 6.70 MALAYSIA MARKET ANALYSIS BY SERVICE TYPE
    71. 6.71 MALAYSIA MARKET ANALYSIS BY BIOLOGICS TYPE
    72. 6.72 MALAYSIA MARKET ANALYSIS BY SCALE OF OPERATION
    73. 6.73 MALAYSIA MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
    74. 6.74 MALAYSIA MARKET ANALYSIS BY END USER
    75. 6.75 THAILAND MARKET ANALYSIS BY SERVICE TYPE
    76. 6.76 THAILAND MARKET ANALYSIS BY BIOLOGICS TYPE
    77. 6.77 THAILAND MARKET ANALYSIS BY SCALE OF OPERATION
    78. 6.78 THAILAND MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
    79. 6.79 THAILAND MARKET ANALYSIS BY END USER
    80. 6.80 INDONESIA MARKET ANALYSIS BY SERVICE TYPE
    81. 6.81 INDONESIA MARKET ANALYSIS BY BIOLOGICS TYPE
    82. 6.82 INDONESIA MARKET ANALYSIS BY SCALE OF OPERATION
    83. 6.83 INDONESIA MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
    84. 6.84 INDONESIA MARKET ANALYSIS BY END USER
    85. 6.85 REST OF APAC MARKET ANALYSIS BY SERVICE TYPE
    86. 6.86 REST OF APAC MARKET ANALYSIS BY BIOLOGICS TYPE
    87. 6.87 REST OF APAC MARKET ANALYSIS BY SCALE OF OPERATION
    88. 6.88 REST OF APAC MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
    89. 6.89 REST OF APAC MARKET ANALYSIS BY END USER
    90. 6.90 SOUTH AMERICA MARKET ANALYSIS
    91. 6.91 BRAZIL MARKET ANALYSIS BY SERVICE TYPE
    92. 6.92 BRAZIL MARKET ANALYSIS BY BIOLOGICS TYPE
    93. 6.93 BRAZIL MARKET ANALYSIS BY SCALE OF OPERATION
    94. 6.94 BRAZIL MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
    95. 6.95 BRAZIL MARKET ANALYSIS BY END USER
    96. 6.96 MEXICO MARKET ANALYSIS BY SERVICE TYPE
    97. 6.97 MEXICO MARKET ANALYSIS BY BIOLOGICS TYPE
    98. 6.98 MEXICO MARKET ANALYSIS BY SCALE OF OPERATION
    99. 6.99 MEXICO MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
    100. 6.100 MEXICO MARKET ANALYSIS BY END USER
    101. 6.101 ARGENTINA MARKET ANALYSIS BY SERVICE TYPE
    102. 6.102 ARGENTINA MARKET ANALYSIS BY BIOLOGICS TYPE
    103. 6.103 ARGENTINA MARKET ANALYSIS BY SCALE OF OPERATION
    104. 6.104 ARGENTINA MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
    105. 6.105 ARGENTINA MARKET ANALYSIS BY END USER
    106. 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY SERVICE TYPE
    107. 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY BIOLOGICS TYPE
    108. 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY SCALE OF OPERATION
    109. 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
    110. 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
    111. 6.111 MEA MARKET ANALYSIS
    112. 6.112 GCC COUNTRIES MARKET ANALYSIS BY SERVICE TYPE
    113. 6.113 GCC COUNTRIES MARKET ANALYSIS BY BIOLOGICS TYPE
    114. 6.114 GCC COUNTRIES MARKET ANALYSIS BY SCALE OF OPERATION
    115. 6.115 GCC COUNTRIES MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
    116. 6.116 GCC COUNTRIES MARKET ANALYSIS BY END USER
    117. 6.117 SOUTH AFRICA MARKET ANALYSIS BY SERVICE TYPE
    118. 6.118 SOUTH AFRICA MARKET ANALYSIS BY BIOLOGICS TYPE
    119. 6.119 SOUTH AFRICA MARKET ANALYSIS BY SCALE OF OPERATION
    120. 6.120 SOUTH AFRICA MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
    121. 6.121 SOUTH AFRICA MARKET ANALYSIS BY END USER
    122. 6.122 REST OF MEA MARKET ANALYSIS BY SERVICE TYPE
    123. 6.123 REST OF MEA MARKET ANALYSIS BY BIOLOGICS TYPE
    124. 6.124 REST OF MEA MARKET ANALYSIS BY SCALE OF OPERATION
    125. 6.125 REST OF MEA MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
    126. 6.126 REST OF MEA MARKET ANALYSIS BY END USER
    127. 6.127 KEY BUYING CRITERIA OF HEALTHCARE
    128. 6.128 RESEARCH PROCESS OF MRFR
    129. 6.129 DRO ANALYSIS OF HEALTHCARE
    130. 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    131. 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    132. 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
    133. 6.133 HEALTHCARE, BY SERVICE TYPE, 2024 (% SHARE)
    134. 6.134 HEALTHCARE, BY SERVICE TYPE, 2024 TO 2035 (USD Billion)
    135. 6.135 HEALTHCARE, BY BIOLOGICS TYPE, 2024 (% SHARE)
    136. 6.136 HEALTHCARE, BY BIOLOGICS TYPE, 2024 TO 2035 (USD Billion)
    137. 6.137 HEALTHCARE, BY SCALE OF OPERATION, 2024 (% SHARE)
    138. 6.138 HEALTHCARE, BY SCALE OF OPERATION, 2024 TO 2035 (USD Billion)
    139. 6.139 HEALTHCARE, BY PRODUCTION TECHNOLOGY, 2024 (% SHARE)
    140. 6.140 HEALTHCARE, BY PRODUCTION TECHNOLOGY, 2024 TO 2035 (USD Billion)
    141. 6.141 HEALTHCARE, BY END USER, 2024 (% SHARE)
    142. 6.142 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
    143. 6.143 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.2.2 BY BIOLOGICS TYPE, 2025-2035 (USD Billion)
      3. 7.2.3 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
      4. 7.2.4 BY PRODUCTION TECHNOLOGY, 2025-2035 (USD Billion)
      5. 7.2.5 BY END USER, 2025-2035 (USD Billion)
    2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.3.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.3.2 BY BIOLOGICS TYPE, 2025-2035 (USD Billion)
      3. 7.3.3 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
      4. 7.3.4 BY PRODUCTION TECHNOLOGY, 2025-2035 (USD Billion)
      5. 7.3.5 BY END USER, 2025-2035 (USD Billion)
    3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
      1. 7.4.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.4.2 BY BIOLOGICS TYPE, 2025-2035 (USD Billion)
      3. 7.4.3 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
      4. 7.4.4 BY PRODUCTION TECHNOLOGY, 2025-2035 (USD Billion)
      5. 7.4.5 BY END USER, 2025-2035 (USD Billion)
    4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.5.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.5.2 BY BIOLOGICS TYPE, 2025-2035 (USD Billion)
      3. 7.5.3 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
      4. 7.5.4 BY PRODUCTION TECHNOLOGY, 2025-2035 (USD Billion)
      5. 7.5.5 BY END USER, 2025-2035 (USD Billion)
    5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
      1. 7.6.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.6.2 BY BIOLOGICS TYPE, 2025-2035 (USD Billion)
      3. 7.6.3 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
      4. 7.6.4 BY PRODUCTION TECHNOLOGY, 2025-2035 (USD Billion)
      5. 7.6.5 BY END USER, 2025-2035 (USD Billion)
    6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
      1. 7.7.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.7.2 BY BIOLOGICS TYPE, 2025-2035 (USD Billion)
      3. 7.7.3 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
      4. 7.7.4 BY PRODUCTION TECHNOLOGY, 2025-2035 (USD Billion)
      5. 7.7.5 BY END USER, 2025-2035 (USD Billion)
    7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
      1. 7.8.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.8.2 BY BIOLOGICS TYPE, 2025-2035 (USD Billion)
      3. 7.8.3 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
      4. 7.8.4 BY PRODUCTION TECHNOLOGY, 2025-2035 (USD Billion)
      5. 7.8.5 BY END USER, 2025-2035 (USD Billion)
    8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
      1. 7.9.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.9.2 BY BIOLOGICS TYPE, 2025-2035 (USD Billion)
      3. 7.9.3 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
      4. 7.9.4 BY PRODUCTION TECHNOLOGY, 2025-2035 (USD Billion)
      5. 7.9.5 BY END USER, 2025-2035 (USD Billion)
    9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
      1. 7.10.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.10.2 BY BIOLOGICS TYPE, 2025-2035 (USD Billion)
      3. 7.10.3 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
      4. 7.10.4 BY PRODUCTION TECHNOLOGY, 2025-2035 (USD Billion)
      5. 7.10.5 BY END USER, 2025-2035 (USD Billion)
    10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
      1. 7.11.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.11.2 BY BIOLOGICS TYPE, 2025-2035 (USD Billion)
      3. 7.11.3 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
      4. 7.11.4 BY PRODUCTION TECHNOLOGY, 2025-2035 (USD Billion)
      5. 7.11.5 BY END USER, 2025-2035 (USD Billion)
    11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.12.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.12.2 BY BIOLOGICS TYPE, 2025-2035 (USD Billion)
      3. 7.12.3 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
      4. 7.12.4 BY PRODUCTION TECHNOLOGY, 2025-2035 (USD Billion)
      5. 7.12.5 BY END USER, 2025-2035 (USD Billion)
    12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.13.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.13.2 BY BIOLOGICS TYPE, 2025-2035 (USD Billion)
      3. 7.13.3 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
      4. 7.13.4 BY PRODUCTION TECHNOLOGY, 2025-2035 (USD Billion)
      5. 7.13.5 BY END USER, 2025-2035 (USD Billion)
    13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
      1. 7.14.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.14.2 BY BIOLOGICS TYPE, 2025-2035 (USD Billion)
      3. 7.14.3 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
      4. 7.14.4 BY PRODUCTION TECHNOLOGY, 2025-2035 (USD Billion)
      5. 7.14.5 BY END USER, 2025-2035 (USD Billion)
    14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
      1. 7.15.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.15.2 BY BIOLOGICS TYPE, 2025-2035 (USD Billion)
      3. 7.15.3 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
      4. 7.15.4 BY PRODUCTION TECHNOLOGY, 2025-2035 (USD Billion)
      5. 7.15.5 BY END USER, 2025-2035 (USD Billion)
    15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
      1. 7.16.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.16.2 BY BIOLOGICS TYPE, 2025-2035 (USD Billion)
      3. 7.16.3 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
      4. 7.16.4 BY PRODUCTION TECHNOLOGY, 2025-2035 (USD Billion)
      5. 7.16.5 BY END USER, 2025-2035 (USD Billion)
    16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
      1. 7.17.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.17.2 BY BIOLOGICS TYPE, 2025-2035 (USD Billion)
      3. 7.17.3 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
      4. 7.17.4 BY PRODUCTION TECHNOLOGY, 2025-2035 (USD Billion)
      5. 7.17.5 BY END USER, 2025-2035 (USD Billion)
    17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
      1. 7.18.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.18.2 BY BIOLOGICS TYPE, 2025-2035 (USD Billion)
      3. 7.18.3 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
      4. 7.18.4 BY PRODUCTION TECHNOLOGY, 2025-2035 (USD Billion)
      5. 7.18.5 BY END USER, 2025-2035 (USD Billion)
    18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
      1. 7.19.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.19.2 BY BIOLOGICS TYPE, 2025-2035 (USD Billion)
      3. 7.19.3 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
      4. 7.19.4 BY PRODUCTION TECHNOLOGY, 2025-2035 (USD Billion)
      5. 7.19.5 BY END USER, 2025-2035 (USD Billion)
    19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
      1. 7.20.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.20.2 BY BIOLOGICS TYPE, 2025-2035 (USD Billion)
      3. 7.20.3 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
      4. 7.20.4 BY PRODUCTION TECHNOLOGY, 2025-2035 (USD Billion)
      5. 7.20.5 BY END USER, 2025-2035 (USD Billion)
    20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.21.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.21.2 BY BIOLOGICS TYPE, 2025-2035 (USD Billion)
      3. 7.21.3 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
      4. 7.21.4 BY PRODUCTION TECHNOLOGY, 2025-2035 (USD Billion)
      5. 7.21.5 BY END USER, 2025-2035 (USD Billion)
    21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.22.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.22.2 BY BIOLOGICS TYPE, 2025-2035 (USD Billion)
      3. 7.22.3 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
      4. 7.22.4 BY PRODUCTION TECHNOLOGY, 2025-2035 (USD Billion)
      5. 7.22.5 BY END USER, 2025-2035 (USD Billion)
    22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
      1. 7.23.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.23.2 BY BIOLOGICS TYPE, 2025-2035 (USD Billion)
      3. 7.23.3 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
      4. 7.23.4 BY PRODUCTION TECHNOLOGY, 2025-2035 (USD Billion)
      5. 7.23.5 BY END USER, 2025-2035 (USD Billion)
    23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
      1. 7.24.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.24.2 BY BIOLOGICS TYPE, 2025-2035 (USD Billion)
      3. 7.24.3 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
      4. 7.24.4 BY PRODUCTION TECHNOLOGY, 2025-2035 (USD Billion)
      5. 7.24.5 BY END USER, 2025-2035 (USD Billion)
    24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
      1. 7.25.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.25.2 BY BIOLOGICS TYPE, 2025-2035 (USD Billion)
      3. 7.25.3 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
      4. 7.25.4 BY PRODUCTION TECHNOLOGY, 2025-2035 (USD Billion)
      5. 7.25.5 BY END USER, 2025-2035 (USD Billion)
    25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.26.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.26.2 BY BIOLOGICS TYPE, 2025-2035 (USD Billion)
      3. 7.26.3 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
      4. 7.26.4 BY PRODUCTION TECHNOLOGY, 2025-2035 (USD Billion)
      5. 7.26.5 BY END USER, 2025-2035 (USD Billion)
    26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.27.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.27.2 BY BIOLOGICS TYPE, 2025-2035 (USD Billion)
      3. 7.27.3 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
      4. 7.27.4 BY PRODUCTION TECHNOLOGY, 2025-2035 (USD Billion)
      5. 7.27.5 BY END USER, 2025-2035 (USD Billion)
    27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
      1. 7.28.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.28.2 BY BIOLOGICS TYPE, 2025-2035 (USD Billion)
      3. 7.28.3 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
      4. 7.28.4 BY PRODUCTION TECHNOLOGY, 2025-2035 (USD Billion)
      5. 7.28.5 BY END USER, 2025-2035 (USD Billion)
    28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
      1. 7.29.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.29.2 BY BIOLOGICS TYPE, 2025-2035 (USD Billion)
      3. 7.29.3 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
      4. 7.29.4 BY PRODUCTION TECHNOLOGY, 2025-2035 (USD Billion)
      5. 7.29.5 BY END USER, 2025-2035 (USD Billion)
    29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.30.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.30.2 BY BIOLOGICS TYPE, 2025-2035 (USD Billion)
      3. 7.30.3 BY SCALE OF OPERATION, 2025-2035 (USD Billion)
      4. 7.30.4 BY PRODUCTION TECHNOLOGY, 2025-2035 (USD Billion)
      5. 7.30.5 BY END USER, 2025-2035 (USD Billion)
    30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.31.1
    1. 7.32 ACQUISITION/PARTNERSHIP
  10. 7.32.1

Healthcare Market Segmentation

Healthcare By Service Type (USD Billion, 2025-2035)

  • Process Development
  • Analytical Development
  • Quality Control Testing
  • Clinical Manufacturing
  • Commercial Manufacturing

Healthcare By Biologics Type (USD Billion, 2025-2035)

  • Monoclonal Antibodies
  • Recombinant Proteins
  • Cell and Gene Therapies
  • Vaccines

Healthcare By Scale of Operation (USD Billion, 2025-2035)

  • Small Scale
  • Medium Scale
  • Large Scale

Healthcare By Production Technology (USD Billion, 2025-2035)

  • Mammalian Cell Culture
  • Microbial Fermentation
  • Plant-based Expression Systems

Healthcare By End User (USD Billion, 2025-2035)

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academic Institutions

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓